Menu
J Clin Aesthet Dermatol. 2021;14(7):16–21 by Martin Wade, BMed Sci, MBBS, FACD; Vanessa Charest, BSc; Bruno Ballardin, B. Eng, MBA; Deirdre Edge, PhD; and Michael Canova Engelbrecht Nielsen, PhD Dr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England. Drs. Edge and Nielsen are with Guangdong Klox
J Clin Aesthet Dermatol. 2021;14(5 Suppl 1):S8–S30. © µ µ ? A message from the Guest Editor and MauiDerm Program Director, George Martin, MD Dear Colleagues: The 2021 edition of the Maui Derm for Dermatologists meeting had a variety of clinical and scientific data presented, but not just at the podium. A wide range of clinically
J Clin Aesthet Dermatol. 2021;14(3):32–37. by James Q. Del Rosso, DO, and Emil Tanghetti, MD Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada, is with Thomas Dermatology in Las Vegas, Nevada, and is an adjunct clinical professor of dermatology at Touro University Nevada in Henderson, Nevada. Dr. Tanghetti is
J Clin Aesthet Dermatol. 2021;14(3):42–45. by Andres Luque, MD; AIDA PAOLA ROJAS, MD; Andrea Ortiz-Florez, MD; and Juliana Perez-Bernal, MD All authors are with Hospital Universitario Centro Dermatológico Federico Lleras in Bogotá, Colombia. FUNDING: No funding was provided for this article. DISCLOSURES: The authors report no conflicts of interest relevant to the content of this
J Clin Aesthet Dermatol. 2021;14(3):E53–E57. by Terry M. Jones, MD, and Iain Stuart, PhD Dr. Jones is with J&S Studies Inc., in College Station, Texas. Dr. Stuart is with VYNE Therapeutics Inc., in Bridgewater, New Jersey. FUNDING: This study was sponsored by Foamix Pharmaceuticals Ltd., a wholly owned subsidiary of VYNE Therapeutics Inc. DISCLOSURES: Dr.
